This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
The installation of the Atlantic Zeiser Digiline 300 provides customers with a solution to one of the biggest challenges currently facing the pharmaceutical industry - the introduction of track and trace technology for new serialization standards.
The investment will support track and trace capability for product movement as well as provide authentication, improved brand protection and increased consumer confidence.
The finished cartons are fed into a coding stream that utilizes a print head and UV dryer allowing fast coding speeds, while the twin vericam camera data inspection system verifies application. This facilitates application, code verification to the master data and readability. An automated rejection process is also included.
Mark Rooney, COO for Clondalkin Pharma & Healthcare Specialist Packaging Division (SPD) highlighted the flexible nature of the equipment: "Many pharmaceutical companies are responding to the challenge of serialization standards by upgrading or installing lines capable of applying a track and trace identifier, but this is often confined to 2D barcoding and batch specific data.
"We have the capability to individually code products of various sizes including flat cartons both glued and unglued. The system can receive and manage multiple data files and print multiple code. The wide print head with multiple image print capability in direction of feed allows 2d matrix and code 128 possible in separate locations once within same print width profile. Should the need occur additional print heads can be added to extend the print location capability. The two separate camera verification scanning units ensure quality of code read and verification of code, or multiple code to the master input data”
Malcolm Farnan, Sales and Marketing Director for Clondalkin Pharma & Healthcare SPD Europe added: “Continued investment is required in order to respond and provide solutions that make it easier for our customers to meet regulation without compromising on efficiency and quality. Our customers approach us to provide solutions from regulatory changes to efficiencies. There are both mass market and niche market demands that are best supported by a competent and experienced packaging supplier rather than in house."
Since the installation of the equipment Clondalkin have been approached by several pharmaceutical companies that have identified it as a good fit to their in house capability and avoids costly line reconfiguration and downtime.
From its three facilities in Ireland Clondalkin Pharma & Healthcare produces a wide range of printed components from cartons, labels and leaflets to clinical trial extended content labels to customers across Ireland, the UK , Europe and the US.
Globally Clondalkin Group's Specialist Packaging Division has 24 production sites throughout North America and Europe and includes folding cartons, labels, leaflets, literature and inserts/outserts businesses, along with paper packaging and printing components. It operates across an extensive range of markets including pharmaceuticals, cosmetics, toiletries and confectionery.
